Breast Cancer Metastases Use 3D Branching Architecture to Spread and Grow

This groundbreaking study reveals why some breast cancers become deadly while others remain contained, identifying a crucial 3D architectural process that drives metastatic growth. Understanding how cancer spreads and grows at distant sites has been a major challenge in oncology, with significant implications for treatment strategies.

Researchers combined cutting-edge techniques including single-cell RNA sequencing, spatial transcriptomics, and AI-supported 3D imaging to study human breast cancer samples alongside functional experiments in mice. They discovered that successful metastases activate a specific genetic program called metastatic trabecular morphogenesis (MTM) that repurposes developmental branching processes.

The key finding is that deadly metastases don't grow as solid masses but instead construct themselves as 3D branching networks of epithelial cords, similar to how blood vessels or lung airways develop during embryonic growth. Primary tumors destined to metastasize already contain cells with high MTM activity, while non-metastatic tumors show low MTM and grow in compact patterns. The researchers identified ETV1/4/5 transcription factors as master controllers of this branching process.

Crucially, this branching architecture is required for metastatic outgrowth but not for initial tumor formation or early spread, suggesting a therapeutic window. The study also identified fibroblast growth factor (FGF) signaling as a druggable pathway that supports this deadly branching process, offering potential new treatment approaches specifically targeting the most lethal stage of cancer progression.